Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Study identifies areas for cancer care cost and quality improvements

Study identifies areas for cancer care cost and quality improvements

Acetylon initiates ACY-1215 Phase 1-2a clinical trial for multiple myeloma

Acetylon initiates ACY-1215 Phase 1-2a clinical trial for multiple myeloma

Financial and political commitments to improve health of women and children

Financial and political commitments to improve health of women and children

Regulatory bias against taking oral anti-cancer medications with food places patients at risk of overdose

Regulatory bias against taking oral anti-cancer medications with food places patients at risk of overdose

Revolution in drug discovery underway in West Midlands, UK

Revolution in drug discovery underway in West Midlands, UK

New insight into how nervous system regulates immunity

New insight into how nervous system regulates immunity

Vesicular stomatitis virus kills cancer cells

Vesicular stomatitis virus kills cancer cells

Celecoxib inhibits GSK3 enzyme in lung cancer cells

Celecoxib inhibits GSK3 enzyme in lung cancer cells

Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study

Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study

Tensha raises $15 million in Series A financing to advance bromodomains for cancer

Tensha raises $15 million in Series A financing to advance bromodomains for cancer

EpiCept announces FDA's feedback on Ceplene clinical development for AML

EpiCept announces FDA's feedback on Ceplene clinical development for AML

Researchers use ultrasound to improve quality of blood stem cell transplant

Researchers use ultrasound to improve quality of blood stem cell transplant

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

Researchers discover gene mutation linked with lymphoedema, leukaemia

Researchers discover gene mutation linked with lymphoedema, leukaemia

Researchers discover group of mutations involved in T-cell acute lymphoblastic leukemia

Researchers discover group of mutations involved in T-cell acute lymphoblastic leukemia

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Going bananas may help kids breathe easier

Going bananas may help kids breathe easier

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

More strides against childhood cancer

More strides against childhood cancer

Chromatin might have another life as direct signaling molecule

Chromatin might have another life as direct signaling molecule

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.